Progress Software (NASDAQ:PRGS) reported quarterly earnings of $1.00 per share which beat the analyst consensus estimate of $0.97 by 3.09 percent. This is a 15.25 percent decrease over earnings of $1.18 per share from the same period last year. The company reported quarterly sales of $151.20 million which beat the analyst consensus estimate of $148.32 million by 1.94 percent. This is a 0.92 percent decrease over sales of $152.60 million the same period last year.
UK Becomes First Major Market for Eli Lilly’s Mounjaro Prefilled Pen For Tackling Obesity
Eli Lilly's popular obesity and diabetes drug, Mounjaro (tirzepatide), hits the UK market this week. Superdrug and Simple Pharmacy offer accessible prescriptions for NHS and private patients.
